0001209191-17-059614.txt : 20171107
0001209191-17-059614.hdr.sgml : 20171107
20171107164334
ACCESSION NUMBER: 0001209191-17-059614
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171103
FILED AS OF DATE: 20171107
DATE AS OF CHANGE: 20171107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wechsler Daniel Mark
CENTRAL INDEX KEY: 0001582285
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35405
FILM NUMBER: 171183945
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
CITY: LAVAL
STATE: A8
ZIP: H7L 4A8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MELINTA THERAPEUTICS, INC. /NEW/
CENTRAL INDEX KEY: 0001461993
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262644445
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6320 QUADRANGLE DRIVE
STREET 2: SUITE 360
CITY: CHAPEL HILL
STATE: NC
ZIP: 27517-8149
BUSINESS PHONE: 919-576-2306
MAIL ADDRESS:
STREET 1: 6320 QUADRANGLE DRIVE
STREET 2: SUITE 360
CITY: CHAPEL HILL
STATE: NC
ZIP: 27517-8149
FORMER COMPANY:
FORMER CONFORMED NAME: CEMPRA, INC.
DATE OF NAME CHANGE: 20120203
FORMER COMPANY:
FORMER CONFORMED NAME: Cempra Holdings, LLC
DATE OF NAME CHANGE: 20090414
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-11-03
0
0001461993
MELINTA THERAPEUTICS, INC. /NEW/
MLNT
0001582285
Wechsler Daniel Mark
C/O MELINTA THERAPEUTICS, INC.
300 GEORGE STREET, SUITE 301
NEW HAVEN
CT
06511
1
1
0
0
President and CEO
Stock Option (Right to Buy)
11.63
2017-11-03
4
A
0
550981
0.00
A
2027-11-03
Common Stock
550981
550981
D
Restricted Stock Units
0.00
2017-11-03
4
A
0
183661
0.00
A
Common Stock
183661
183661
D
The award vests 25% on November 3, 2018 and the remainder will vest in equal monthly installments during the 3 years following the initial vesting date, subject to the Reporting Person's continued employment with the Issuer.
/s/ S. Halle Vakani, by Power of Attorney
2017-11-07